Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingkepingchuan Keli Granules for Pediatric Acute Bronchitis (Phase III)
CTR20243704Phase 3Active
- Sponsor
- Changchun Leiyunshang Pharmaceutical
- Start
- Oct 2024
- Countries
- 1
01
Overview
A Phase 3 trial of qingkepingchuan in acute bronchitis, sponsored by Changchun Leiyunshang Pharmaceutical. Started Oct 2024; status: active.
02
Drugs
qingkepingchuan
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20243704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243704.